<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: clinical trials</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Client-directed therapy technique drastically reduces divorce/separation rates</title>
   	 <description>Using four simple questions to generate client-directed feedback can greatly increase the chances that struggling couples will stay together, according to a recently published study.</description>
     <link>http://www.physorg.com/news177335341.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 13 Nov 2009 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news177335341</guid>
</item>
<item>
     <title>New evidence that dark chocolate helps ease emotional stress</title>
   	 <description>The "chocolate cure" for emotional stress is getting new support from a clinical trial published online in ACS' Journal of Proteome Research.</description>
     <link>http://www.physorg.com/news177165080.html</link>
	 <category>Chemistry</category>
	 <pubDate>Wed, 11 Nov 2009 12:32:18 EST</pubDate>
	 <guid isPermaLink="false">news177165080</guid>
</item>
<item>
     <title>Researchers mobilizing global resources to test new treatments for severe H1N1 infection</title>
   	 <description>An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic.</description>
     <link>http://www.physorg.com/news177156409.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 11 Nov 2009 10:20:01 EST</pubDate>
	 <guid isPermaLink="false">news177156409</guid>
</item>
<item>
     <title>Drug shrinks lung cancer tumors in mice</title>
   	 <description>(PhysOrg.com) -- A potential new drug for lung cancer has eliminated tumours in 50% of mice in a new study published today in the journal Cancer Research. In the animals, the drug also stopped lung cancer tumours from growing and becoming resistant to treatment. The authors of the research, from Imperial College London, are now planning to take the drug into clinical trials, to establish whether it could offer hope to patients with an inoperable form of lung cancer.</description>
     <link>http://www.physorg.com/news177083483.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 10 Nov 2009 13:52:13 EST</pubDate>
	 <guid isPermaLink="false">news177083483</guid>
</item>
<item>
     <title>Stem cells restore mobility in neck-injured rats (w/ Video)</title>
   	 <description>(PhysOrg.com) -- The first human embryonic stem cell treatment approved by the FDA for human testing has been shown to restore limb function in rats with neck spinal cord injuries - a finding that could expand the clinical trial to include people with cervical damage.</description>
     <link>http://www.physorg.com/news176993886.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 10 Nov 2009 07:54:28 EST</pubDate>
	 <guid isPermaLink="false">news176993886</guid>
</item>
<item>
     <title>Say yes to a clinical trial; it may be good for your health</title>
   	 <description>Patients with chronic heart failure who agree to take part in clinical trials have a better prognosis than those who do not, according to a study reported in the November European Journal of Heart Failure.(1) The finding, say the authors, may even call into question the commonplace ethical requirement of most clinical trials that by choosing not to take part in the study a patient will not be disadvantaged.</description>
     <link>http://www.physorg.com/news176116041.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 30 Oct 2009 10:30:01 EST</pubDate>
	 <guid isPermaLink="false">news176116041</guid>
</item>
<item>
     <title>Swine flu vaccine must be free and safe for high uptake</title>
   	 <description>Almost half of adults surveyed in Summer 2009 in Hong Kong (45%) say they would take up free swine flu vaccination. However, this figure drops to around 1 in 7 (15%) if the price they have to pay for the vaccine reaches $HK200 (£16; €17; $26). In the absence of proved efficacy and safety, the figure decreases to less than 1 in 20 (5%), according to one of the first studies on behavioural intentions and A/H1N1 vaccination, published in the British Medical Journal today.</description>
     <link>http://www.physorg.com/news175936505.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 28 Oct 2009 08:15:55 EST</pubDate>
	 <guid isPermaLink="false">news175936505</guid>
</item>
<item>
     <title>Recommended treatment for heart failure often underused</title>
   	 <description>Less than one-third of patients hospitalized for heart failure and participating in a quality improvement registry received a guideline-recommended treatment of heart failure, aldosterone antagonist therapy, according to a study in the October 21 issue of JAMA.</description>
     <link>http://www.physorg.com/news175274754.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 20 Oct 2009 16:40:01 EST</pubDate>
	 <guid isPermaLink="false">news175274754</guid>
</item>
<item>
     <title>Centralized Review Process Markedly Expedites Approval of Cancer Clinical Trials</title>
   	 <description>(PhysOrg.com) -- A Central Institutional Review Board (CIRB) for cancer clinical trials that was created by the National Cancer Institute (NCI), part of the National Institutes of Health, in 2001 helps trials start more quickly (just over a month faster, on average) and thus expedite the time from concept to completion of crucial investigational research according to a new finding. This study of the CIRB was performed by scientists at the Veterans Affairs Palo Alto Health Care System (VAPAHCS) and Stanford University School of Medicine, Palo Alto, Calif., with assistance from NCI and appears online October 19, 2009 in the Journal of Clinical Oncology.</description>
     <link>http://www.physorg.com/news175198083.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 19 Oct 2009 19:30:02 EST</pubDate>
	 <guid isPermaLink="false">news175198083</guid>
</item>
<item>
     <title>Designing drugs and their antidotes together improves patient care</title>
   	 <description>Imagine a surgical patient on a blood-thinning drug who starts bleeding more than expected, and an antidote that works immediately - because the blood thinner and antidote were designed to work together. Researchers at Duke University Medical Center have engineered a way to do this for an entire, versatile class of drugs called aptamers and published their findings in Nature Medicine.</description>
     <link>http://www.physorg.com/news173881624.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 04 Oct 2009 13:28:50 EST</pubDate>
	 <guid isPermaLink="false">news173881624</guid>
</item>
<item>
     <title>As swine flu intensifies, US rolls out first vaccine doses</title>
   	 <description> US health authorities are hoping to contain what they say is an intensifying swine flu pandemic with a massive A(H1N1) vaccination campaign that begins this Tuesday.</description>
     <link>http://www.physorg.com/news173841614.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 04 Oct 2009 02:50:02 EST</pubDate>
	 <guid isPermaLink="false">news173841614</guid>
</item>
<item>
     <title>3 Questions: AIDS researchers on new vaccine results</title>
   	 <description>(PhysOrg.com) -- On Thursday, an international research team reported that a new AIDS vaccine tested in more than 16,000 volunteers in Thailand protected a small but significant minority against infection. The new results mark the first time any vaccine has shown even partial success in clinical trials.</description>
     <link>http://www.physorg.com/news173425498.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 29 Sep 2009 07:10:02 EST</pubDate>
	 <guid isPermaLink="false">news173425498</guid>
</item>
<item>
     <title>Considering usual medical care in clinical trial design</title>
   	 <description>In this week's PLoS Medicine, Liza Dawson (National Institutes of Health) and colleagues discuss the scientific and ethical issues associated with choosing clinical trial designs when there is no consensus on what constitutes usual care. </description>
     <link>http://www.physorg.com/news173419133.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 29 Sep 2009 04:59:22 EST</pubDate>
	 <guid isPermaLink="false">news173419133</guid>
</item>
<item>
     <title>Revolutionary drug could be new hope for adrenal cancer patients</title>
   	 <description>TGen Clinical Research Services at Scottsdale Healthcare today announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that attacks the adrenal glands.</description>
     <link>http://www.physorg.com/news172842178.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 22 Sep 2009 12:44:11 EST</pubDate>
	 <guid isPermaLink="false">news172842178</guid>
</item>
<item>
     <title>Can an over-the-counter vitamin-like substance slow the progression of Parkinson's disease?</title>
   	 <description>Rush University Medical Center is participating in a large-scale, multi-center clinical trial in the U.S. and Canada to determine whether a vitamin-like substance, in high doses, can slow the progression of Parkinson's disease, a neurodegenerative disorder that affects about one million people in the United States.</description>
     <link>http://www.physorg.com/news172762049.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 21 Sep 2009 14:40:03 EST</pubDate>
	 <guid isPermaLink="false">news172762049</guid>
</item>
<item>
     <title>National trial to test new treatment for chronic, severe indigestion</title>
   	 <description>Could medicines used for depression also treat chronic, severe indigestion? Scientists at Mayo Clinic suspect they can and, backed by funding from the National Institutes of Health (NIH), they are testing that premise in a nationwide clinical trial.</description>
     <link>http://www.physorg.com/news172403221.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 17 Sep 2009 11:00:01 EST</pubDate>
	 <guid isPermaLink="false">news172403221</guid>
</item>
<item>
     <title>Tuberculosis patients can reduce transmissability by inhaling interferon through a nebulizer</title>
   	 <description>A new study published in the September 15, 2009, issue of PLoS ONE found that patients with cavitary pulmonary tuberculosis receiving anti-TB medications supplemented with nebulized interferon-gamma have fewer bacilli in the lungs and less inflammation, thereby reducing the transmissibility of tuberculosis in the early phase of treatment.</description>
     <link>http://www.physorg.com/news172216198.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 15 Sep 2009 07:20:01 EST</pubDate>
	 <guid isPermaLink="false">news172216198</guid>
</item>
<item>
     <title>Discovery leads to rapid mouse 'personalized trials' in breast cancer</title>
   	 <description>One person's breast cancer is not the same as another person's, because the gene mutations differ in each tumor. That makes it difficult to match the best therapy with the individual patient.</description>
     <link>http://www.physorg.com/news171296471.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 04 Sep 2009 15:21:49 EST</pubDate>
	 <guid isPermaLink="false">news171296471</guid>
</item>
<item>
     <title>Cuban cancer drug undergoes rare U.S. trial</title>
   	 <description>For the first time since Fidel Castro took power in Cuba over a half-century ago, a drug developed by the Communist regime is going through clinical trials in the United States.</description>
     <link>http://www.physorg.com/news171277649.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 04 Sep 2009 10:30:02 EST</pubDate>
	 <guid isPermaLink="false">news171277649</guid>
</item>
<item>
     <title>New report describes types of research conducted at academic medical centers</title>
   	 <description>A study from the Massachusetts General Hospital (MGH) Institute for Health Policy gives the first detailed look at the types of research currently being conducted within U.S. academic medical centers - medical schools and their affiliated hospitals.  The report in the Sept. 2 Journal of the American Medical Association describes how the traditional way of categorizing life-science researchers as either basic or applied clinical investigators does not adequately reflect the reality of today's academic medical research.</description>
     <link>http://www.physorg.com/news171044651.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Sep 2009 17:37:10 EST</pubDate>
	 <guid isPermaLink="false">news171044651</guid>
</item>
<item>
     <title>Researchers aim to stretch limited supply of flu vaccine</title>
   	 <description>Worried there won't be enough of the swine flu vaccine? Stanford University researchers are beginning clinical trials to determine if vaccines for the swine flu virus, also known as H1N1, could be stretched by lowering the dosage and coupling it with a booster.</description>
     <link>http://www.physorg.com/news171007567.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Sep 2009 07:40:01 EST</pubDate>
	 <guid isPermaLink="false">news171007567</guid>
</item>
<item>
     <title>Telemonitoring: A bridge to personalized medicine</title>
   	 <description>An increasing number of heart failure patients are treated with a number of complex devices, i.e. cardiac resynchronization therapy (CRT).  Recently completed and ongoing clinical trials such as MADIT-CRT and EchoCRT provide evidence of a growing number of CRT patients, in need of individualised treatment. Rising demand for implantable cardiac devices and the simultaneous need for increased efficiency as well as enhanced patient comfort and safety significantly increase the need for remote monitoring technology.</description>
     <link>http://www.physorg.com/news171007694.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Sep 2009 07:20:01 EST</pubDate>
	 <guid isPermaLink="false">news171007694</guid>
</item>
<item>
     <title>Cornell makes cancer vaccine for clinical use</title>
   	 <description>The Bioproduction Facility at Cornell University has produced the first batch of NY-ESO-1 recombinant protein -a cancer vaccine -that will be used in clinical trials for patients facing either ovarian cancer or melanoma.  The facility was developed as a partnership between The Ludwig Institute for Cancer Research and Cornell University.</description>
     <link>http://www.physorg.com/news170013469.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 20 Aug 2009 19:20:01 EST</pubDate>
	 <guid isPermaLink="false">news170013469</guid>
</item>
<item>
     <title>Study shows carvedilol is effective in preventing variceal bleeding in cirrhotic patients</title>
   	 <description>Patients with cirrhosis are at risk for developing portal hypertension that can lead to the formation, dilation, and rupture of esophageal varices.  The annual incidence of esophageal varices is approximately 5% and one third of those will bleed.</description>
     <link>http://www.physorg.com/news169898284.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 19 Aug 2009 11:10:03 EST</pubDate>
	 <guid isPermaLink="false">news169898284</guid>
</item>
<item>
     <title>Cost-effectiveness of cetuximab in metastatic colorectal cancer</title>
   	 <description>From a health-care system perspective, it may be more efficient to use the drug cetuximab only in colorectal cancer patients whose tumors have a wild-type KRAS gene, according to a study published online August 7 in the Journal of the National Cancer Institute.</description>
     <link>http://www.physorg.com/news168929397.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sat, 08 Aug 2009 05:50:31 EST</pubDate>
	 <guid isPermaLink="false">news168929397</guid>
</item>
<item>
     <title>Sanofi Pasteur starts testing swine flu vaccine</title>
   	 <description>(AP) --  French drugmaker Sanofi Pasteur says it has started human trials of its swine flu vaccine in about 2,000 people in the United States.</description>
     <link>http://www.physorg.com/news168849919.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 07 Aug 2009 07:45:46 EST</pubDate>
	 <guid isPermaLink="false">news168849919</guid>
</item>
<item>
     <title>New lab test offers better prediction of HIV microbicide safety</title>
   	 <description>Scientists at Albert Einstein College of Medicine of Yeshiva University have devised a laboratory test for predicting whether microbicides against HIV are safe for human use. The researchers have also discovered why several supposedly "safe" microbicides made women more susceptible to HIV infection. The study appears today in the online version of the Journal of Infectious Disease.</description>
     <link>http://www.physorg.com/news166441689.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 10 Jul 2009 10:48:40 EST</pubDate>
	 <guid isPermaLink="false">news166441689</guid>
</item>
<item>
     <title>The power of prayer?</title>
   	 <description>Health and religion have always been intertwined, most obviously through prayer on behalf of the sick. Does intercessory prayer for sick people actually help heal them? For thousands of years some people have believed so. But new Brandeis University research in the Journal of Religion this month shows that over the last four decades, medical studies of intercessory prayer -the prayer of strangers at a distance -actually say more about the scientists conducting the studies than about the power of prayer to heal.</description>
     <link>http://www.physorg.com/news164471135.html</link>
	 <category>Other Sciences</category>
	 <pubDate>Wed, 17 Jun 2009 16:10:02 EST</pubDate>
	 <guid isPermaLink="false">news164471135</guid>
</item>
<item>
     <title>Brain-computer interface, developed at Brown, begins new clinical trial</title>
   	 <description>BrainGate, an investigational technology being developed to detect brain signals and to allow people with paralysis to use those signals to control assistive devices, is about to begin a second, larger clinical trial. The system is based on neuroscience, engineering and computer science research at Brown University.</description>
     <link>http://www.physorg.com/news163835209.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 10 Jun 2009 06:47:10 EST</pubDate>
	 <guid isPermaLink="false">news163835209</guid>
</item>
<item>
     <title>Women under-represented in most cancer research</title>
   	 <description>Women continue to be under-enrolled in cancer clinical trials, according to a new review, published in the July 15, 2009 issue of CANCER. The study's results suggest that greater efforts are needed to ensure that oncologists know the true effects of treatments and medical procedures in female patients.</description>
     <link>http://www.physorg.com/news163644964.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 08 Jun 2009 01:56:45 EST</pubDate>
	 <guid isPermaLink="false">news163644964</guid>
</item>


</channel>
</rss>

